Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients-Reference-Cited by-同舟云学术

Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients

Published:2019-04-02 Issue:8 Volume:145 Page:2114-2121
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Nabieva Naiba¹^ORCID,Häberle Lothar¹²^ORCID,Brucker Sara Y.³,Janni Wolfgang⁴,Volz Bernhard¹,Loehberg Christian R.¹⁵,Hartkopf Andreas D.³,Walter Christina‐Barbara³,Baake Gerold⁶,Fridman Alexander⁷⁸,Malter Wolfram⁷,Wuerstlein Rachel⁷⁹,Harbeck Nadia⁷⁹,Hoffmann Oliver¹⁰,Kuemmel Sherko¹¹,Martin Bernhard¹²,Thomssen Christoph¹³,Graf Heiko¹⁴,Wolf Christopher¹⁵,Lux Michael P.¹,Bayer Christian M.¹,Rauh Claudia¹,Hack Carolin C.¹,Almstedt Katrin¹¹⁶,Gass Paul¹^ORCID,Heindl Felix¹,Brodkorb Tobias¹,Lindner Christoph¹⁷,Kolberg Hans‐Christian¹⁸,Krabisch Petra¹⁹,Weigel Michael²⁰,Steinfeld‐Birg Dieter²¹,Kohls Andreas²²,Brucker Cosima²³,Schulz Volker²⁴,Fischer Gunnar²⁵,Pelzer Volker²⁶,Rack Brigitte⁴,Beckmann Matthias W.¹,Fehm Tanja³²⁷,Rody Achim²⁸,Maass Nicolai²⁹,Hein Alexander¹,Fasching Peter A.¹^ORCID

Affiliation:

1. Department of GynecologyErlangen University Hospital, Friedrich Alexander University Erlangen–Nuremberg, Comprehensive Cancer Center Erlangen‐EMN Erlangen Germany

2. Biostatistics Unit, Department of GynecologyErlangen University Hospital Erlangen Germany

3. Department of GynecologyUniversity of Tübingen Tübingen Germany

4. Department of GynecologyUlm University Hospital Ulm Germany

5. St. Theresien Hospital Nuremberg Germany

6. Oncological Medical Practice Pinneberg Pinneberg Germany

7. Breast Center, Department of Obstetrics and GynecologyCologne University Hospital Cologne Germany

8. Evangelisches Krankenhaus Kalk Cologne Germany

9. Breast Center, Department of Gynecology and Obstetrics and CCC MunichUniversity of Munich (LMU) Munich Germany

10. Department of GynecologyEssen University Hospital Essen Germany

11. Breast Unit, Essen Mitte ClinicsEvangelische Huyssens‐Stiftung/Knappschaft GmbH Essen Germany

12. Tuttlingen Clinic Tuttlingen Germany

13. Department of GynecologyMartin Luther University of Halle‐Wittenberg Halle (Saale) Germany

14. Helios Clinics Meiningen Meiningen Germany

15. Medical Center Ulm Ulm Germany

16. Department of GynecologyMainz University Hospital Mainz Germany

17. Agaplesion Diakonie Clinic Hamburg Hamburg Germany

18. Department of Gynecology and ObstetricsMarienhospital Bottrop Bottrop Germany

19. Department of GynecologyClinic of Chemnitz gGmbH Chemnitz Germany

20. Department of GynecologyLeopoldina Hospital Schweinfurt Schweinfurt Germany

21. Gynecologic Oncologic Practice Steinfeld‐Birg Augsburg Germany

22. Protestant County Hospital of Ludwigsfelde‐Teltow Ludwigsfelde‐Teltow Germany

23. Department of Gynecology and Obstetrics, Nuremberg General HospitalParacelsus Medical University Nuremberg Germany

24. Gynecologic Practice abts+partner Kiel Germany

25. Mittweida Hospital gGmbH Mittweida Germany

26. Department of GynecologyGFO Clinics Bonn Bonn Germany

27. Department of GynecologyHeinrich Heine University of Dusseldorf Dusseldorf Germany

28. Department of GynecologySchleswig‐Holstein University Hospital, Campus Lübeck Schleswig‐Holstein Germany

29. Department of GynecologySchleswig‐Holstein University Hospital, Campus Kiel Schleswig‐Holstein Germany

Funder

Novartis

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32294

Reference29 articles.

1. Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus

2. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

3. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

4. Analyses Adjusting for Selective Crossover Show Improved Overall Survival With Adjuvant Letrozole Compared With Tamoxifen in the BIG 1-98 Study

5. A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemische Therapie von prämenopausalen Patientinnen mit hormonrezeptorpositivem, HER2-negativem Brustkrebs in den Frühstadien – Kontroversen und Standards in der Krankenversorgung;Senologie - Zeitschrift für Mammadiagnostik und -therapie;2024-03

2. Current and future advances in practice: aromatase inhibitor–induced arthralgia;Rheumatology Advances in Practice;2024-01-01

3. Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare;Geburtshilfe und Frauenheilkunde;2023-05-23

4. Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer;Frontiers in Oncology;2022-12-12

5. Update Mammakarzinom 2022 Teil 2 – Brustkrebs in fortgeschrittenen Krankheitsstadien;Senologie - Zeitschrift für Mammadiagnostik und -therapie;2022-12